SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042118
Filing Date
2021-08-12
Accepted
2021-08-12 17:17:26
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_adialpharma.htm   iXBRL 10-Q 789384
2 CERTIFICATION EXHIBIT f10q0621ex31-1_adialpharma.htm EX-31.1 10279
3 CERTIFICATION EXHIBIT f10q0621ex31-2_adialpharma.htm EX-31.2 10054
4 CERTIFICATION EXHIBIT f10q0621ex32-1_adialpharma.htm EX-32.1 4149
5 CERTIFICATION EXHIBIT f10q0621ex32-2_adialpharma.htm EX-32.2 4147
  Complete submission text file 0001213900-21-042118.txt   4591064

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20210630.xsd EX-101.SCH 65227
7 XBRL CALCULATION FILE adil-20210630_cal.xml EX-101.CAL 27689
8 XBRL DEFINITION FILE adil-20210630_def.xml EX-101.DEF 239257
9 XBRL LABEL FILE adil-20210630_lab.xml EX-101.LAB 512861
10 XBRL PRESENTATION FILE adil-20210630_pre.xml EX-101.PRE 254416
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_adialpharma_htm.xml XML 461316
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 211168719
SIC: 2834 Pharmaceutical Preparations